v3.26.1
SEGMENT REPORTING - Schedule of Operating Financial Results of Therapeutics Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues:            
Total revenues $ 173,912   $ 102,660   $ 335,966 $ 180,995
Operating expenses:            
Cost of sales 12,113   6,237   21,509 11,448
Research and development 31,010   15,594   53,361 30,003
General and administrative 150,697   103,013   287,126 188,008
Total operating expenses 193,820   124,844   361,996 229,459
Loss from operations before other income (expense) (19,908)   (22,184)   (26,030) (48,464)
Net loss (18,551) $ (6,967) (20,340) $ (25,120) (25,518) (45,460)
Other segment disclosures:            
Interest income 3,698   4,229   7,420 7,683
Interest expense (2,156)   (2,240)   (4,284) (4,453)
Provision for income taxes 2,716   0   5,068 0
Reportable Segment            
Revenues:            
Total revenues 173,912   102,660   335,966 180,995
Operating expenses:            
Cost of sales 12,113   6,237   21,509 11,448
Research and development 31,010   15,594   53,361 30,003
Selling and marketing 90,002   65,857   174,484 126,143
General and administrative 60,695   37,156   112,642 61,865
Total operating expenses 193,820   124,844   361,996 229,459
Loss from operations before other income (expense) (19,908)   (22,184)   (26,030) (48,464)
Other reconciling items 1,357   1,844   512 3,004
Net loss (18,551)   (20,340)   (25,518) (45,460)
Other segment disclosures:            
Interest income 3,698   4,229   7,420 7,683
Interest expense (2,156)   (2,240)   (4,284) (4,453)
Depreciation and amortization expense (1,000)   (453)   (1,437) (913)
Provision for income taxes (2,716)   0   (5,068) 0
Product sales, net            
Revenues:            
Total revenues 173,912   102,660   319,299 180,995
Product sales, net | Reportable Segment            
Revenues:            
Total revenues 173,912   102,660   319,299 180,995
License fees and collaboration revenue            
Revenues:            
Total revenues 0   0   16,667 0
License fees and collaboration revenue | Reportable Segment            
Revenues:            
Total revenues $ 0   $ 0   $ 16,667 $ 0